Dupilumab Effective for Eosinophilic Esophagitis Up to 52 Weeks Dupilumab Effective for Eosinophilic Esophagitis Up to 52 Weeks

The new biologic will most likely be used in patients refractory to proton pump inhibitors and topical steroids.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news